Search

Your search keyword '"Jansen, Marnix"' showing total 167 results

Search Constraints

Start Over You searched for: Author "Jansen, Marnix" Remove constraint Author: "Jansen, Marnix" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
167 results on '"Jansen, Marnix"'

Search Results

1. 223 IMMUNE CELL PHENOTYPING IN BARRETT'S ESOPHAGUS IN PATIENTS PRIOR AND AT TIME OF PROGRESSION

2. The co-evolution of the genome and epigenome in colorectal cancer

3. Phenotypic plasticity and genetic control in colorectal cancer evolution

4. Immunosuppressive niche engineering at the onset of human colorectal cancer

6. Abstract 4539: Tumor evolution and immune microenvironment dynamics define response to neoadjuvant treatment of esophageal adenocarcinoma

9. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity

10. Mo1164: UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR RISK STRATIFICATION IN PATIENTS WITH BARRETT'S OESOPHAGUS WHO ARE OVERDUE ENDOSCOPIC SURVEILLANCE DUE TO THE COVID-19 PANDEMIC

11. Clonal Transitions and Phenotypic Evolution in Barrett’s Esophagus

14. The natural history of low‐grade dysplasia in Barrett's esophagus and risk factors for progression

15. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

17. Stain-free identification of tissue pathology using a generative adversarial network to infer nanomechanical signatures

18. 253e IMMUNE EDITING IN THE INVASIVE MARGIN AND NODE DEPOSITS OF COLORECTAL CANCER SELECTS FOR CELLULAR NEIGHBOURHOODS ENRICHED IN PDL1+ CANCER CELLS

22. Tu1277 UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR NON-ENDOSCOPIC SURVEILLANCE IN PATIENTS WITH BARRETT'S OESOPHAGUS

23. 225 MITOTIC AGE OF NON-DYSPLASTIC BARRETT'S ESOPHAGUS DEFINES RISK OF PROGRESSION TO ESOPHAGEAL ADENOCARCINOMA USING A NOVEL TARGETED ALLELE SPECIFIC METHYLATION SEQUENCING ARRAY

26. 30 TRACING SPATIAL CLONAL EVOLUTION OF INTESTINAL METAPLASIA IN THE CHRONICALLY INFLAMED STOMACH, A QUANTITATIVE MODEL OF PRE-TUMOUR PROGRESSION.

27. VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies

28. Histopathologist Features Predictive of Diagnostic Concordance at Expert Level Amongst a Large International Sample of Pathologists Diagnosing Barrett’s Dysplasia Using Digital Pathology

29. Undifferentiated sarcomas develop through distinct evolutionary pathways

31. Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus

32. Evolutionary history of human colitis-associated colorectal cancer

33. Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study

34. Quality indicators for Barrett’s endotherapy (QBET): UK consensus statements for patients undergoing endoscopic therapy for Barrett’s neoplasia

35. Sa1160 – The Natural History of Low Grade Dysplasia in Patients with Barrett's Esophagus: 12 Year Retrospective Analysis from a Tertiary Centre

36. Quantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon

37. 781 – Quantifying Evolution of Early Dysplastic Lesions in Ulcerative Colitis Predicts Future Colorectal Cancer Risk

39. Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways

40. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience

41. Quality indicators for Barrett's endotherapy (QBeT): UK consensus statements for patients undergoing endoscopic therapy for Barrett's neoplasia.

42. Abstract 5368: The evolutionary history of human colitis-associated colorectal cancer

45. 335 - Lineage Tracing in Barrett's Esophagus Reveals both its Origins and Evolution and Suggests that Gland Diversity may be an Important Biomarker for the Progression to Dysplasia in Patients

47. Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution

48. Vitamin D3 suppresses morphological evolution of the cribriform cancerous phenotype

Catalog

Books, media, physical & digital resources